Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Inspire presents positive results for dry eye disease therapeutic

May 13, 1999

Targeted delivery of TNP-470 using water-soluble polymer effective in choroidal neovascularization

May 12, 1999

Stability and ocular uptake of BAPSG evaluated in preclinical studies

May 12, 1999

SnET2 photodynamic therapy stabilizes visual acuity in subfoveal choroidal neovascularization

May 11, 1999

Ocufit SR provides sustained release of diclofenac into the sclera

May 11, 1999

AGN-192024 is more effective than timolol in lowering IOP in patients with glaucoma

May 11, 1999

InSite Vision signs agreement with U. of California for glaucoma gene rights

May 4, 1999

Allergen patents new thromboxane receptor ligands with particular utility in ocular hypertension

May 3, 1999

Alcon to continue Lu-Tex development

April 27, 1999

Steroidogenesis inhibitor tested in mouse model of hereditary blindness

April 15, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...